IFNG and neoplasm: In AA samples, assessment of immune cell types and function through TIDE analysis indicated lower tumor-associated macrophage M2, tumor immune dysfunction and exclusion prediction scores, and higher “immune inflamed” and interferon-gamma signatures, which have previously been shown to predict response to immunotherapy.